SG Americas Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.2M | Buy |
|
|||||
|
2024
Q1 | $204K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $145K | Sell |
|
|||||
|
2023
Q1 | $716K | Buy |
|
|||||
|
2022
Q4 | $457K | Buy |
|
|||||
|
2022
Q3 | $289K | Sell |
|
|||||
|
2022
Q2 | $520K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $257K | Sell |
|
|||||
|
2021
Q3 | $740K | Sell |
|
|||||
|
2021
Q2 | $2.09M | Buy |
|